• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索引结肠镜检查中的高级腺瘤数量:结直肠同时性高级别肿瘤的重要危险因素。

Number of advanced adenomas on index colonoscopy: Important risk factor for metachronous advanced colorectal neoplasia.

机构信息

Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Dig Liver Dis. 2018 Jun;50(6):568-572. doi: 10.1016/j.dld.2018.03.001. Epub 2018 Mar 12.

DOI:10.1016/j.dld.2018.03.001
PMID:29588111
Abstract

BACKGROUND/AIMS: Although the patients with multiple advanced adenomas (AA) in index colonoscopy may have an increased risk for subsequent advanced colorectal neoplasia (CRN), the current guidelines do not consider this factor. We aimed to compare the risk of metachronous advanced CRN according to the number of AAs.

METHODS

A total of 2250 patients with ≥1 adenoma at index colonoscopy were included. The patients were divided according to the number of AAs (1, 2 and ≥3 AAs). The relative and 3-year absolute risk of metachronous advanced CRN was compared between the AA groups.

RESULTS

The relative risk of metachronous advanced CRN was higher in the patients with ≥3 AAs than in the patients with one AA (16.7% vs. 6.8%, p = 0.004). The 3-year absolute risk of metachronous advanced CRN was higher in the patients with ≥3 AAs than in the patients with 1-2 AA (19.4% vs. 6.9%, p = 0.04). Having ≥3 AAs (odds ratio, 5.42; 95% confidence interval 1.75-16.83) was a significant risk factor for developing advanced CRN.

CONCLUSIONS

The risk of metachronous advanced CRN in the patients with ≥3 AAs was higher than that in the patients with one or two AAs. More intensive surveillances might be needed for these patient groups.

摘要

背景/目的:尽管在首次结肠镜检查中发现多个进展性腺瘤(AA)的患者可能存在随后发生高级结直肠肿瘤(CRN)的风险增加,但目前的指南并未考虑这一因素。我们旨在根据 AA 的数量比较发生异时性高级 CRN 的风险。

方法

共纳入 2250 名在首次结肠镜检查中至少有 1 个腺瘤的患者。根据 AA 的数量(1、2 和≥3 个 AA)将患者进行分组。比较了 AA 组之间异时性高级 CRN 的相对风险和 3 年绝对风险。

结果

与 1 个 AA 的患者相比,≥3 个 AA 的患者发生异时性高级 CRN 的相对风险更高(16.7%比 6.8%,p=0.004)。与 1-2 个 AA 的患者相比,≥3 个 AA 的患者发生异时性高级 CRN 的 3 年绝对风险更高(19.4%比 6.9%,p=0.04)。存在≥3 个 AA(比值比,5.42;95%置信区间 1.75-16.83)是发生高级 CRN 的显著危险因素。

结论

≥3 个 AA 的患者发生异时性高级 CRN 的风险高于 1 个或 2 个 AA 的患者。这些患者群体可能需要更密集的监测。

相似文献

1
Number of advanced adenomas on index colonoscopy: Important risk factor for metachronous advanced colorectal neoplasia.索引结肠镜检查中的高级腺瘤数量:结直肠同时性高级别肿瘤的重要危险因素。
Dig Liver Dis. 2018 Jun;50(6):568-572. doi: 10.1016/j.dld.2018.03.001. Epub 2018 Mar 12.
2
Risk of advanced colorectal neoplasm by the proposed combined United States and United Kingdom risk stratification guidelines.按美国和英国联合提出的风险分层指南评估结直肠进展性腺瘤的风险。
Gastrointest Endosc. 2018 Mar;87(3):800-808. doi: 10.1016/j.gie.2017.09.023. Epub 2017 Oct 3.
3
The effect of small or diminutive adenomas at baseline colonoscopy on the risk of developing metachronous advanced colorectal neoplasia: KASID multicenter study.基线结肠镜检查中小或微小腺瘤对发生结肠直肠腺瘤性息肉进展的风险的影响:KASID 多中心研究。
Dig Liver Dis. 2018 Aug;50(8):847-852. doi: 10.1016/j.dld.2018.04.001. Epub 2018 Apr 11.
4
Adenoma detection rate influences the risk of metachronous advanced colorectal neoplasia in low-risk patients.腺瘤检出率影响低危患者结直肠腺瘤间期高级别肿瘤的风险。
Gastrointest Endosc. 2018 Mar;87(3):809-817.e1. doi: 10.1016/j.gie.2017.09.028. Epub 2017 Oct 4.
5
Prediction of the Risk of a Metachronous Advanced Colorectal Neoplasm Using a Novel Scoring System.使用新型评分系统预测异时性晚期结直肠肿瘤的风险
Dig Dis Sci. 2016 Oct;61(10):3016-3025. doi: 10.1007/s10620-016-4237-8. Epub 2016 Jun 29.
6
Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry.小腺瘤与微小腺瘤的发生与腺瘤间期高级别腺瘤风险的相关性:来自新罕布什尔州结肠镜检查登记处的数据。
Gastrointest Endosc. 2019 Sep;90(3):495-501. doi: 10.1016/j.gie.2019.05.029. Epub 2019 May 22.
7
Risk of developing metachronous colorectal neoplasia after the resection of proximal versus distal adenomas.近端腺瘤与远端腺瘤切除术后发生异时性结直肠肿瘤的风险。
Dig Liver Dis. 2022 Apr;54(4):537-542. doi: 10.1016/j.dld.2021.08.005. Epub 2021 Aug 22.
8
Coexistent adenoma and serrated polyps on index colonoscopy and the risk of metachronous advanced colorectal neoplasia.初次结肠镜检查时并存的腺瘤和锯齿状息肉与异时性晚期结直肠肿瘤的风险
Endosc Int Open. 2019 Dec;7(12):E1748-E1754. doi: 10.1055/a-1019-2976. Epub 2019 Dec 10.
9
Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas.多发性小或小腺瘤患者息肉切除术后发生异时性高级结直肠腺瘤的风险。
Am J Gastroenterol. 2019 Oct;114(10):1657-1664. doi: 10.14309/ajg.0000000000000296.
10
Risk of advanced colorectal neoplasm in patients with more than 10 adenomas on index colonoscopy: A Korean Association for the Study of Intestinal Diseases (KASID) study.初次结肠镜检查发现10个以上腺瘤的患者发生晚期结直肠肿瘤的风险:韩国肠道疾病研究协会(KASID)的一项研究。
J Gastroenterol Hepatol. 2017 Apr;32(4):803-808. doi: 10.1111/jgh.13626.

引用本文的文献

1
Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal Adenoma.青年结直肠腺瘤患者的发病情况、危险因素和异时性高级别腺瘤风险的系统评价。
Clin Gastroenterol Hepatol. 2021 Apr;19(4):680-689.e12. doi: 10.1016/j.cgh.2020.04.092. Epub 2020 May 16.
2
Risk factors of advanced metachronous neoplasms in surveillance after colon cancer resection.结直肠癌切除术后监测中晚期转移性肿瘤的风险因素。
Korean J Intern Med. 2021 Mar;36(2):305-312. doi: 10.3904/kjim.2019.053. Epub 2020 Apr 21.
3
Coexistent adenoma and serrated polyps on index colonoscopy and the risk of metachronous advanced colorectal neoplasia.
初次结肠镜检查时并存的腺瘤和锯齿状息肉与异时性晚期结直肠肿瘤的风险
Endosc Int Open. 2019 Dec;7(12):E1748-E1754. doi: 10.1055/a-1019-2976. Epub 2019 Dec 10.